{"DataElement":{"publicId":"7576478","version":"1","preferredName":"Immune System Disease or Disorder Atopy Diagnosis Name","preferredDefinition":"Text term that represents the atopy condition.","longName":"IMM_DZ_ATOPY_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7576467","version":"1","preferredName":"Immune System Disease or Disorder Atopy Diagnosis","preferredDefinition":"The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"7576473v1.0:7576474v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"7576473","version":"1","preferredName":"Immune System Disease or Disorder","preferredDefinition":"The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C12735:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System","conceptCode":"C12735","definition":"The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB014D6E-1E07-4032-E053-4EBD850A9D8B","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"ONEDATA","dateModified":"2021-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7576474","version":"1","preferredName":"Atopy Diagnosis","preferredDefinition":"A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C41366:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atopy","conceptCode":"C41366","definition":"A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB014D6E-1E18-4032-E053-4EBD850A9D8B","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"ONEDATA","dateModified":"2021-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB00F62B-6D9E-6724-E053-4EBD850A92F6","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"COOPERM","dateModified":"2021-02-10","changeDescription":"Created for NCI-INC0557438 - 20C0070 curation request. mc 2.9.21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7531545","version":"1","preferredName":"Atopic Immune Disease or Disorder Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"ATOPY_IMM_DZ_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Asthma","valueDescription":"Asthma","ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6348D52-39AD-7D5F-E053-4EBD850AAAAA","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Severe allergies","valueDescription":"Severe Allergic Reaction","ValueMeaning":{"publicId":"7576468","version":"1","preferredName":"Severe Allergic Reaction","longName":"7576468","preferredDefinition":"Intensely bad or unpleasant in degree, quality or extent.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB0111C6-37B1-4D15-E053-4EBD850AA292","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"ONEDATA","dateModified":"2021-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB0111C6-37CA-4D15-E053-4EBD850AA292","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"ONEDATA","dateModified":"2021-02-10","deletedIndicator":"No"},{"value":"Atopic dermatitis","valueDescription":"Eczema","ValueMeaning":{"publicId":"3252129","version":"1","preferredName":"Eczema","longName":"3252129","preferredDefinition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eczema","conceptCode":"C3001","definition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A781D14A-E852-8A44-E040-BB89AD4310FD","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB0111C6-37DE-4D15-E053-4EBD850AA292","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"ONEDATA","dateModified":"2021-02-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6348D52-3979-7D5F-E053-4EBD850AAAAA","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"COOPERM","dateModified":"2021-02-10","changeDescription":"Created for NCI-INC0557438 - 20C0070 curation request. 2.10.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"ATOPY","type":"Preferred Question Text","description":"ATOPY","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB01635F-926B-4290-E053-4EBD850AA322","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"COOPERM","dateModified":"2021-02-10","changeDescription":"Created for NCI-INC0557438 - 20C0070 curation request. mc 2.9.21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}